Erlotinib-related rhabdomyolysis: the role of pharmacogenetics and drug–drug interaction

被引：0
|
作者：
Marta Koršić
Davorka Muršić
Sonja Badovinac
Nada Božina
Mihovil Roglić
Marko Jakopović
Branka Čučević
机构：
[1] University Hospital Centre Zagreb,Clinic for Lung Diseases Jordanovac
[2] University Hospital Centre Zagreb,Clinical Institute of Laboratory Diagnosis
来源：
Cancer Chemotherapy and Pharmacology | 2015年 / 76卷
关键词：
Imatinib; Erlotinib; Oxycodone; Creatine Kinase Level; Serum Creatine Kinase;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1317 / 1319
页数：2
相关论文
共 50 条
  • [41] Tacrolimus nephrotoxicity: beware of the association of diarrhea, drug interaction and pharmacogenetics
    Leroy, Sandrine
    Isapof, Arnaud
    Fargue, Sonia
    Fakhoury, May
    Bensman, Albert
    Deschenes, Georges
    Jacqz-Aigrain, Evelyne
    Ulinski, Tim
    PEDIATRIC NEPHROLOGY, 2010, 25 (05) : 965 - 969
  • [42] In silico based evaluation of efavirenz and rifampicin drug-drug interaction considering weight and pharmacogenetics
    Rekic, D.
    Roshammar, D.
    Ashton, M.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2009, 14 : 51 - 52
  • [43] Applications of pharmacogenetics in drug therapy and drug development
    Kirchheiner, J
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 691 - 692
  • [44] Drug-Drug Interactions with Consideration of Pharmacogenetics
    Ozawa, Shogo
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2018, 138 (03): : 365 - 371
  • [45] Effect of erlotinib on the pharmacokinetics of irinotecan and its metabolites: A drug-drug interaction study.
    Sanematsu, Emiko
    Toyooka, Issei
    Takashima, Yuki
    Okimoto, Tamio
    Tsubata, Yukari
    Saito, Hideyuki
    Isobe, Takeshi
    Hamada, Akinobu
    CANCER RESEARCH, 2013, 73 (08)
  • [46] Pharmacokinetic drug-drug interaction between erlotinib and paracetamol: A potential risk for clinical practice
    Karbownik, Agnieszka
    Szalek, Edyta
    Sobanska, Katarzyna
    Grabowski, Tomasz
    Wolc, Anna
    Grzeskowiak, Edmund
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 102 : 55 - 62
  • [47] Rhabdomyolysis secondary to drug interaction between atorvastatin, omeprazole, and dexamethasone
    Elazzazy, Shereen
    Eziada, Saad S.
    Zaidan, Manal
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2012, 5 : 59 - 61
  • [48] Drug induced rhabdomyolysis
    Hohenegger, Martin
    CURRENT OPINION IN PHARMACOLOGY, 2012, 12 (03) : 335 - 339
  • [49] STATIN-ASSOCIATED RHABDOMYOLYSIS WITH RENAL FAILURE AS A CONSEQUENCE OF DRUG-DRUG INTERACTION WITH ERYTHROMYCIN
    Heron, V.
    Wilkinson, S.
    Young, A.
    Nicholson, M.
    Govindarajulu, S.
    Venuthurupalli, S.
    NEPHROLOGY, 2018, 23 : 73 - 73
  • [50] Pharmacogenetics of folate-related drug targets in cancer treatment
    Robien, K
    Boynton, A
    Ulrich, CM
    PHARMACOGENOMICS, 2005, 6 (07) : 673 - 689
12345